Non-PVC IV Bags Market Growth Accelerated by Increasing Adoption of Non-Toxic Products
![]() |
Non-PVC IV Bags Market |
Non-PVC
IV bags are medical devices that deliver medications, fluids, blood and
electrolytes to patients undergoing medical treatments and surgery through
intravenous method. Made from non-toxic materials like polyethylene and
polypropylene, these bags help avoid harmful effects associated with PVC such
as toxicity, plasticizers and medical waste. They ensure safe administration of
treatment to patients and help in reducing environmental pollution. The global
Non-PVC IV Bags Market is estimated to be valued at US$ 1.2 billion in 2023 and
is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of non-PVC IV bags is mainly driven by the growing
awareness about adverse effects of PVC among patients and healthcare providers.
Various studies have established association between PVC and toxicity issues
like leaching of phthalates plasticizers which can potentially harm patients
undergoing long term treatments. Non-PVC bags are free from such risks and
allow for safer treatment of chronic diseases like cancer requiring lengthy IV
therapies. Many countries have also imposed regulatory norms favoring usage of
non-toxic alternatives to PVC in medical devices. This growing regulatory push
along with rising health conscious consumer behavior is expected to boost the
non-PVC IV bags market substantially over the forecast period.
Segment
Analysis
The global non-PVC IV bags market is dominated by the crystalline polymers
sub-segment. Crystalline polymers such as polyolefins provide superior strength
and breaking resistance as compared to other material like lipids, which makes
them ideal for manufacturing IV bags. These bags can withstand high
temperatures during autoclaving or sterilization processes.
Key Takeaways
The Global
Non-PVC IV Bags Market Demand is expected to witness high growth over
the forecast period of 2023 to 2030.
Regional analysis: North America region currently dominates the non-PVC IV bags
market due to stringent regulations banning use of PVC and presence of major
players. The region is expected to continue its dominance owing to growing
healthcare expenditure and increasing adoption of non-PVC materials. Asia
Pacific region is expected to register fastest growth during the forecast period
majorly due to rising medical tourism in countries like India and China.
Key players operating in the non-PVC IV bags market are Baxter, Sippex,
B.Braun, Kawasumi Laboratories, Medline, and Renolit.
For
more details on the report, Read- https://www.insightprobing.com/non-pvc-iv-bags-market-demand-share-analysis/
Comments
Post a Comment